 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/5 mg comp.x 28 | $66.921,36 | (19/06/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 160/12.5/10 mg comp.x 28 | $66.284,67 | (19/06/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.333,99 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $66.921,36 | (19/06/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $66.921,36 | (19/06/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $70.773,09 | (19/06/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $34.523,46 |
|
|
|
|
| |
